You will be logged off in  seconds due to inactivity. Click here to continue using this web page.

Alt-R HDR Donor Block Entry

0 items
Name Sequence Length Scale NGS Score
0 items
In accordance with the Harmonized Screening Protocol created by the International Gene Synthesis Consortium, and in order protect the safety of IDT personnel, IDT requires that the following disclosure be completed by the ordering researcher, or by an authorized representative of the ordering institution prior to the acceptance of any Synthetic Biology order.
Biohazard screening guidelines allow us to accept the electronic signature included during the Web ordering process as long as the form is filled out correctly. The form includes a question asking whether the gBlock sequence originates from a plant or animal pathogen. If you order sequences from any pathogen please click the 'Yes' radio button and enter a brief description of the sequence. This will avoid the need for a written form and the delays associated with the process.
Does the requested cloned DNA sequence encode (either fully or partially) a toxin? If 'Other', please specify

Does the requested DNA sequence originate in a plant or animal pathogen?

Does the requested DNA sequence encode a replication competent and/or infectious form of a virus, or a form of DNA which, by itself, could replicate within its host?

Does the requested cloned DNA sequence encode for an etiologic agent (something which causes or may cause human disease)?

Does the gene element encode a product that can interfere with cloning or propagation in bacterial hosts?


Typing your name in the box below will serve as your digital signature. By providing your digital signature you agree to the following:
  1. You are the person named below.
  2. You are the person who will be directly working with the requested material or will be responsible for the individuals working with the material.
  3. The purchase of, shipment to, and acceptance of the genetic material in this order is legal in the country in which this order will be received, and you are in compliance with all regulations regarding the possession and use of said materials. For US customers this includes but is not limited to those described in the current HHS and USDA Select Agents and Toxins 7CFR Part 331, 9 CFR Part 121, and 42 CFR Part 73.
  4. You agree to prevent the distribution of this material to any individual, group, or entity that is not lawfully permitted to possess said material, or whose possession or use may endanger the safety of themselves or others.


IDT's Terms and Conditions for Synthetic Biology Ordering

All pricing information conveyed by IDT applies to the exact sequences as ordered. IDT reserves the right to change the price of a sequence altered after ordering by the customer. If IDT is unable to successfully assemble the product as ordered, the customer may be offered a partial product as a "best effort" with a reduced fee determined at IDT's discretion. If, by nature of the product's sequence, IDT is unable to obtain complete QC, the customer shall accept incomplete coverage and is still liable for the full cost of the product. All turn-around time (TAT) statements are estimations of expected turn-around time and are not binding on IDT. Turn-around time estimates are for information purposes only, and delays of any kind shall not relieve the customer of its obligations to pay the full invoice price. IDT reserves the right to cancel a product order at any time. All changes to price and cancellation will be communicated to the customer.